JP2022095666A5 - - Google Patents

Download PDF

Info

Publication number
JP2022095666A5
JP2022095666A5 JP2022041655A JP2022041655A JP2022095666A5 JP 2022095666 A5 JP2022095666 A5 JP 2022095666A5 JP 2022041655 A JP2022041655 A JP 2022041655A JP 2022041655 A JP2022041655 A JP 2022041655A JP 2022095666 A5 JP2022095666 A5 JP 2022095666A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
positions
amino acids
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022041655A
Other languages
English (en)
Japanese (ja)
Other versions
JP7432640B2 (ja
JP2022095666A (ja
Filing date
Publication date
Priority claimed from PCT/US2017/019953 external-priority patent/WO2017151617A1/en
Application filed filed Critical
Publication of JP2022095666A publication Critical patent/JP2022095666A/ja
Publication of JP2022095666A5 publication Critical patent/JP2022095666A5/ja
Application granted granted Critical
Publication of JP7432640B2 publication Critical patent/JP7432640B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022041655A 2016-02-29 2022-03-16 感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド Active JP7432640B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662301426P 2016-02-29 2016-02-29
US62/301,426 2016-02-29
PCT/US2017/019953 WO2017151617A1 (en) 2016-02-29 2017-02-28 Stapled intracellular-targeting antimicrobial peptides to treat infection
JP2018545479A JP7105696B2 (ja) 2016-02-29 2017-02-28 感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018545479A Division JP7105696B2 (ja) 2016-02-29 2017-02-28 感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド

Publications (3)

Publication Number Publication Date
JP2022095666A JP2022095666A (ja) 2022-06-28
JP2022095666A5 true JP2022095666A5 (https=) 2022-07-13
JP7432640B2 JP7432640B2 (ja) 2024-02-16

Family

ID=59679412

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018545479A Active JP7105696B2 (ja) 2016-02-29 2017-02-28 感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド
JP2022041655A Active JP7432640B2 (ja) 2016-02-29 2022-03-16 感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018545479A Active JP7105696B2 (ja) 2016-02-29 2017-02-28 感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド

Country Status (7)

Country Link
US (3) US20170247423A1 (https=)
EP (1) EP3423075B1 (https=)
JP (2) JP7105696B2 (https=)
CN (1) CN109069578A (https=)
AU (1) AU2017228333C1 (https=)
CA (1) CA3014442A1 (https=)
WO (1) WO2017151617A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3317294B1 (en) * 2015-07-02 2023-03-15 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides
CA3014442A1 (en) 2016-02-29 2017-09-08 Dana-Farber Cancer Institute, Inc. Stapled intracellular-targeting antimicrobial peptides to treat infection
AU2018304230A1 (en) 2017-07-19 2020-02-06 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
US11865181B2 (en) 2017-11-03 2024-01-09 Yale University Peptidic materials that traffic efficiently to the cell cytosol and nucleus
EP3724216A1 (en) 2017-12-15 2020-10-21 Dana Farber Cancer Institute, Inc. Stabilized peptide-mediated targeted protein degradation
US11952432B2 (en) 2018-02-07 2024-04-09 Dana-Farber Cancer Institute, Inc. Cell-permeable stapled peptide modules for cellular delivery
WO2019178313A1 (en) 2018-03-14 2019-09-19 Dana-Farber Cancer Institute, Inc. Stabilized peptides for biomarker detection
CN109870583B (zh) * 2019-04-15 2020-03-06 德阳市人民医院 急性胰腺炎相关的代谢物及其应用
CN120383667B (zh) * 2024-04-16 2026-03-13 山东第一医科大学(山东省医学科学院) 一种具有抗菌作用的订书肽及其应用

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861478A (en) 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
US5912231A (en) 1989-07-07 1999-06-15 Scripps Clinic And Research Foundation Substitution analogues of magainin peptides
WO1991000869A1 (en) 1989-07-07 1991-01-24 Scripps Clinic And Research Foundation Substitution analogues of magainin peptides
US5607914A (en) 1993-01-13 1997-03-04 Pioneer Hi-Bred International, Inc. Synthetic antimicrobial peptides
US5561107A (en) 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
US5446090A (en) 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
US5885829A (en) 1996-05-28 1999-03-23 The Regents Of The University Of Michigan Engineering oral tissues
US20020064546A1 (en) 1996-09-13 2002-05-30 J. Milton Harris Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
KR100263583B1 (ko) * 1997-05-28 2000-08-01 박종헌 항균 펩타이드의 대량 제조방법 및 그에 유용한 플라즈미드 벡타
PT1053019E (pt) 1998-01-07 2004-04-30 Debio Rech Pharma Sa Acrilatos de poli(etileno-glicol) heterobifuncional degradaveis e geles e conjugados derivados dos mesmos
HUP0100575A3 (en) 1998-01-21 2003-03-28 Merck Sharp & Dohme Ltd Hoddes Triazolo-pyridazine derivatives as ligands for gaba receptors
KR100314721B1 (ko) 1998-01-22 2001-11-23 김일웅 생물학적 활성이 있는 신규한 펩타이드
AU5006499A (en) 1998-07-23 2000-02-14 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the treatment or prevention of pulmonary infections
US6288212B1 (en) * 1998-08-28 2001-09-11 The University Of British Columbia Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
US6562785B1 (en) * 1999-03-23 2003-05-13 Howard M. Shapiro Method for overcoming bacterial antibiotic resistance
DE19914817A1 (de) 1999-03-31 2000-10-05 Petry Genmedics Gmbh Dr Wirkstoffe zur Bekämpfung von bakteriellen Infektionserkrankungen
US6262071B1 (en) 1999-06-29 2001-07-17 Smithkline Beecham Corporation Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria
JP2003531101A (ja) 1999-06-29 2003-10-21 スミスクライン・ビーチャム・コーポレイション 細菌に対するフルオロキノロン化合物の使用法
US20030143234A1 (en) * 1999-08-20 2003-07-31 Wenyuan Shi Anti-microbial targeting chimeric pharmaceutical
US6348558B1 (en) 1999-12-10 2002-02-19 Shearwater Corporation Hydrolytically degradable polymers and hydrogels made therefrom
BR0001870B1 (pt) 2000-05-29 2014-02-25 Peptídeo, processo de obtenção de peptídeo, formulação compreendendo peptídeo, método de prevenção de crescimento de parasitas, fungos e bactérias, método para inativar a endotoxina de bactérias gram-negativas
CA2441562C (en) 2001-03-28 2013-05-14 Helix Biomedix, Inc. Short bioactive peptides and methods for their use
CN1158304C (zh) 2001-05-10 2004-07-21 上海华谊生物技术有限公司 蛙皮抗菌肽衍生物
KR100614714B1 (ko) 2001-06-15 2006-08-21 에프. 호프만-라 로슈 아게 ｇｐ41 단편의 아세틸화
US6620954B1 (en) 2002-03-25 2003-09-16 Eastman Chemical Company Phosphinometallocenylamides as novel ligands for asymmetric catalysis
WO2003083441A2 (en) 2002-03-29 2003-10-09 Buck Institute Identification of apoptotic peptides and methods of use thereof
ES2586387T3 (es) 2003-11-05 2016-10-14 Dana-Farber Cancer Institute, Inc. Péptidos alfa helicoidales adecuados para activar o inhibir la muerte celular
US7745390B2 (en) * 2005-05-23 2010-06-29 The Board Of Trustees Of The Leland Stanford Junior University Antimicrobial peptides
EP2010520B1 (en) 2006-04-20 2012-09-12 Pfizer Products Inc. Heterobicyclic amides for the prevention and treatment of glucokinase-mediated diseases
WO2008058575A1 (de) 2006-11-17 2008-05-22 Osram Gesellschaft mit beschränkter Haftung Modulares flächen- leuchtsystem
WO2008086042A2 (en) 2007-01-10 2008-07-17 Chisari Francis V Preventing infection by a measles or respiratory syncytial virus
DK2118123T3 (en) 2007-01-31 2016-01-25 Dana Farber Cancer Inst Inc Stabilized p53 peptides and uses thereof
US8592377B2 (en) 2007-03-28 2013-11-26 President And Fellows Of Harvard College Stitched polypeptides
AU2008256689A1 (en) 2007-05-24 2008-12-04 New York Blood Center Inc. Rapidly dispersible vaginal tablet that provides a bioadhesive gel
CA2700925C (en) 2007-09-26 2016-08-23 Dana Farber Cancer Institute Methods and compositions for modulating bcl-2 family polypeptides
EP2247606B1 (en) 2008-01-23 2019-08-21 Dana-Farber Cancer Institute, Inc. Compositions and methods for the treatment of viral infections
US20100069308A1 (en) 2008-06-06 2010-03-18 Chorny Iiya Surfaces containing antibacterial polymers
US8586707B2 (en) 2008-09-16 2013-11-19 The Research Foundation Of State University Of New York Stapled peptides and method of synthesis
EP2346521A4 (en) 2008-10-06 2012-06-20 Univ Colorado Regents PEPTIDES AND USE METHOD THEREFOR
BRPI0920899A2 (pt) 2008-11-24 2016-04-26 Aileron Therapeutics Inc macrociclos peptidomiméticos com propriedades melhoradas
GB0821687D0 (en) 2008-11-28 2008-12-31 Secr Defence Peptides
KR20100065639A (ko) 2008-12-08 2010-06-17 건국대학교 산학협력단 새로운 피시딘 유도체 항생 펩타이드 및 그 용도
EP3549951A3 (en) 2008-12-09 2019-11-20 Dana Farber Cancer Institute, Inc. Methods and compositions for specific modulation of mcl-1
AU2010263056B2 (en) 2009-06-18 2016-01-07 Dana Farber Cancer Institute, Inc. Structured viral peptide compositions and methods of use
DK2445515T3 (en) * 2009-06-26 2016-07-04 Univ Leuven Kath antimicrobial agents
US20130139930A1 (en) 2009-12-18 2013-06-06 Latitude 18, Inc. Inorganic phosphate corrosion resistant coatings
EP2590997B1 (en) 2010-07-09 2018-04-04 Dana-Farber Cancer Institute, Inc. Stabilized insulinotropic peptides and methods of use
AU2012242502B2 (en) 2011-04-15 2016-07-28 Dana-Farber Cancer Institute, Inc. Targeting deregulated WNT signaling in cancer using stabilized alpha-helices of BCL-9
DE102012203547A1 (de) * 2012-03-07 2013-09-12 Robert Bosch Gesellschaft Für Medizinische Forschung Mbh Antimikrobielle Peptide
EP2755986A4 (en) 2011-09-12 2015-05-20 Moderna Therapeutics Inc MANIPULATED NUCLEIC ACIDS AND METHOD OF APPLICATION THEREFOR
WO2013049567A1 (en) 2011-09-29 2013-04-04 The Broad Institute, Inc. Compounds for the treatment of mycobacterial infections
US8669226B2 (en) * 2011-10-07 2014-03-11 Morehouse School Of Medicine Antimicrobial compositions and methods of use thereof
CA2862391C (en) 2011-12-29 2023-10-10 Loren D. Walensky Stabilized antiviral fusion helices
WO2013148677A1 (en) * 2012-03-26 2013-10-03 University Of Florida Research Foundation, Inc. Antimicrobial compounds and their use in treating plant disease
RU2694758C2 (ru) 2012-12-20 2019-07-16 Раджив Бхушан Антимикробные композиции
CN103164738B (zh) 2013-02-06 2015-09-30 厦门盛华电子科技有限公司 一种基于移动支付多通道数字认证的手机用户识别卡
EP3391898A3 (en) 2013-03-13 2019-02-13 President and Fellows of Harvard College Stapled and stitched polypeptides and uses thereof
EP2970418A4 (en) 2013-03-15 2016-08-17 Dana Farber Cancer Inst Inc STABILIZED EZH2 PEPTIDES
AU2014227824B2 (en) 2013-03-15 2018-09-27 Dana-Farber Cancer Institute, Inc. Stabilized SOS1 peptides
WO2015070912A1 (en) 2013-11-14 2015-05-21 Lysando Ag Modified el188 endolysin sequence
EP3096616B1 (en) 2014-01-24 2020-04-29 The Regents of the University of Colorado, a Body Corporate Dermaseptin-type and piscidin-type antimicrobial peptides
WO2015138494A1 (en) * 2014-03-10 2015-09-17 Georges Belfort Anti-microbial peptides and method for designing novel anti-microbial peptides
US10507227B2 (en) 2014-04-15 2019-12-17 The Hospital For Sick Children Cationic antimicrobial peptides
EP3317294B1 (en) 2015-07-02 2023-03-15 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides
US20190048038A1 (en) 2016-02-23 2019-02-14 Dana-Farber Cancer Institute, Inc. Method for generating cell-penetrating stapled peptides that lack nonspecific membrane-lytic properties for therapeutic targeting
CA3014442A1 (en) 2016-02-29 2017-09-08 Dana-Farber Cancer Institute, Inc. Stapled intracellular-targeting antimicrobial peptides to treat infection
AU2018304230A1 (en) 2017-07-19 2020-02-06 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
US20230116760A1 (en) 2019-12-16 2023-04-13 Dana-Farber Cancer Institute, Inc. Structurally-stabilized oncolytic peptides and uses thereof

Similar Documents

Publication Publication Date Title
JP2022095666A5 (https=)
EP3274472B1 (en) Antimicrobial peptides and methods of use thereof
US6288212B1 (en) Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
JP2019513696A5 (https=)
CN111087460B (zh) 一种广谱型抗菌肽及其应用
CN111658761A (zh) 天然宿主防御肽Cm-CATH2的应用
KR20160055343A (ko) 왕지네로부터 유래한 항균 펩타이드 스콜로펜드라신-7 및 그의 조성물
KR101444261B1 (ko) 왕지네로부터 분리한 신규 스콜로펜드라신ⅰ펩타이드 및 그의 조성물
EP3681468A1 (en) Antimicrobial composition
CN114853865B (zh) 一种改造体抗菌肽dsNCM1及其应用
KR20180117792A (ko) 왕귀뚜라미에서 유래한 항균 펩타이드 테레오그릴루신 1 및 그의 조성물
CN115947802A (zh) 一种抗菌物质吉类菌素的制备及重组表达方法和医用用途
US20210261623A1 (en) Theta defensin analogs and methods of use
KR20180117793A (ko) 왕귀뚜라미에서 유래한 항균 펩타이드 테레오그릴루신 2 및 그의 조성물
CN118767111A (zh) 一种抗耐药菌活性肽Hydrostatin-AMP3在治疗细菌性脓毒症中的应用
US6413510B1 (en) Dimeric modified groβ protein
Yamada et al. Effect of modified oligopeptides from the beetle Allomyrina dichotoma on Escherichia coli infection in mice
JPH03101698A (ja) 新規ポリペプチドおよびそれらの使用
Kosmidis et al. Fleroxacin in single dose oral therapy of uncomplicated lower urinary tract infection
JP5240811B2 (ja) マダイ滑走細菌症ワクチン及びマダイ滑走細菌症ワクチン組成物並びにマダイ滑走細菌症の予防法
JP2009516520A5 (https=)
CN119185514B (zh) Fgf8蛋白在制备抗菌剂中的应用
CN114652716B (zh) 地美硝唑在制备抗β-内酰胺类耐药性大肠杆菌药物中的应用
ES2867401T3 (es) Composiciones antibacterianas con actividad mejorada
Bello et al. Salmonella dublin neck abscess